Carret Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,243
| Closed | -$428K | – | 286 |
|
|
2024
Q2 | $428K | Sell |
6,243
-800
| -11% | -$53.4K | 0.05% | 194 |
|
|
2024
Q1 | $516K | Buy |
7,043
+700
| +11% | +$53.8K | 0.06% | 191 |
|
|
2023
Q4 | $514K | Sell |
6,343
-17
| -0.3% | -$1.32K | 0.07% | 189 |
|
|
2023
Q3 | $477K | Sell |
6,360
-75
| -1% | -$5.77K | 0.07% | 186 |
|
|
2023
Q2 | $496K | Sell |
6,435
-350
| -5% | -$27.9K | 0.07% | 186 |
|
|
2023
Q1 | $563K | Sell |
6,785
-250
| -4% | -$20.7K | 0.08% | 171 |
|
|
2022
Q4 | $604K | Sell |
7,035
-555
| -7% | -$44K | 0.08% | 165 |
|
|
2022
Q3 | $468K | Sell |
7,590
-250
| -3% | -$15.8K | 0.07% | 186 |
|
|
2022
Q2 | $485K | Sell |
7,840
-300
| -4% | -$18.6K | 0.07% | 185 |
|
|
2022
Q1 | $484K | Buy |
8,140
+940
| +13% | +$60.1K | 0.06% | 199 |
|
|
2021
Q4 | $523K | Hold |
7,200
| – | – | 0.06% | 197 |
|
|
2021
Q3 | $503K | Sell |
7,200
-600
| -8% | -$42.2K | 0.06% | 194 |
|
|
2021
Q2 | $537K | Hold |
7,800
| – | – | 0.06% | 193 |
|
|
2021
Q1 | $504K | Sell |
7,800
-129
| -2% | -$8.32K | 0.06% | 186 |
|
|
2020
Q4 | $462K | Sell |
7,929
-200
| -2% | -$12.1K | 0.06% | 181 |
|
|
2020
Q3 | $514K | Buy |
8,129
+650
| +9% | +$45.1K | 0.08% | 165 |
|
|
2020
Q2 | $575K | Buy |
7,479
+1,000
| +15% | +$76.6K | 0.09% | 149 |
|
|
2020
Q1 | $484K | Sell |
6,479
-1,000
| -13% | -$69.1K | 0.09% | 147 |
|
|
2019
Q4 | $486K | Buy |
7,479
+425
| +6% | +$27.7K | 0.07% | 177 |
|
|
2019
Q3 | $447K | Hold |
7,054
| – | – | 0.07% | 180 |
|
|
2019
Q2 | $477K | Buy |
7,054
+1,114
| +19% | +$73.3K | 0.08% | 179 |
|
|
2019
Q1 | $386K | Buy |
5,940
+1,100
| +23% | +$73.1K | 0.06% | 188 |
|
|
2018
Q4 | $303K | Sell |
4,840
-1,791
| -27% | -$125K | 0.05% | 199 |
|
|
2018
Q3 | $512K | Hold |
6,631
| – | – | 0.08% | 176 |
|
|
2018
Q2 | $470K | Buy |
6,631
+500
| +8% | +$35.3K | 0.08% | 180 |
|
|
2018
Q1 | $462K | Sell |
6,131
-350
| -5% | -$27.8K | 0.08% | 180 |
|
|
2017
Q4 | $464K | Sell |
6,481
-300
| -4% | -$22.8K | 0.07% | 181 |
|
|
2017
Q3 | $549K | Buy |
6,781
+1,000
| +17% | +$76.5K | 0.09% | 161 |
|
|
2017
Q2 | $409K | Sell |
5,781
-700
| -11% | -$46.6K | 0.07% | 184 |
|
|
2017
Q1 | $440K | Sell |
6,481
-12,400
| -66% | -$872K | 0.08% | 173 |
|
|
2016
Q4 | $1.35M | Sell |
18,881
-880
| -4% | -$65.4K | 0.26% | 93 |
|
|
2016
Q3 | $1.56M | Buy |
19,761
+13,705
| +226% | +$1.11M | 0.29% | 86 |
|
|
2016
Q2 | $505K | Buy |
6,056
+2,050
| +51% | +$182K | 0.1% | 149 |
|
|
2016
Q1 | $368K | Sell |
4,006
-600
| -13% | -$54.1K | 0.08% | 169 |
|
|
2015
Q4 | $466K | Buy |
4,606
+841
| +22% | +$87.5K | 0.1% | 156 |
|
|
2015
Q3 | $370K | Buy |
3,765
+740
| +24% | +$82.2K | 0.08% | 173 |
|
|
2015
Q2 | $354K | Buy |
+3,025
| New | +$331K | 0.07% | 184 |
|
Other funds holding GILD
Carret Asset Management's GILD Position: Q3 2024 in Review
Carret Asset Management sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 6,243 shares — an estimated $428K sold.
Carret Asset Management first reported a position in GILD in Q2 2015 and held it in 37 quarters. The position peaked at $1.56M in Q3 2016. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.
- Carret Asset Management reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
- Carret Asset Management sold 6,243 Gilead Sciences shares in Q3 2024, an estimated $428K.
- Carret Asset Management first reported a position in Gilead Sciences in Q2 2015 and held it in 37 quarters.
- Carret Asset Management's Gilead Sciences position peaked at $1.56M in Q3 2016.
- 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.
Based on Carret Asset Management's 13F filing for Q3 2024, filed 24 Oct 2024.